Vincent Okungu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Vincent Okungu has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Jane Chuma
Kenya Medical Research Institute-Wellcome Trust Research Programme, P.O Box, 230, Kilifi, Kenya
5 shared publications Catherine Molyneux
Kenya Medical Research Institute-Wellcome Trust Research Programme, P.O Box, 230, Kilifi, Kenya
4 shared publicationsChijioke Osinachi Nwosu
University of the Free State
3 shared publicationsChinyere Ojiugo Mbachu
University of Nigeria
3 shared publicationsDaniel Malik Achala
African Health Economics and Policy Association
3 shared publications- Di McIntyre
Health Economics Unit, University of Cape Town, Cape Town, South Africa
3 shared publications
Latest Publications
- Open Access
- 4 September 2026
- Published by Frontiers Media SA in Frontiers in Health Services
- Vol. 6, 1974455
Correction: Scoping review of COVID-19 vaccines access, equity, hesitancy, and uptake in Kenya: lessons for the next pandemic
A Correction on: Okungu V, Mulupi S, Muriithi GN, Achala DM, Adote E, Mbachu CO, Beshaha SA, Nwosu CO and Ataguba JE-O (2026) The funding of the article processing charges was erroneously omitted. The following text has now been added to the Funding statement: "The article processing charges for this article were funded by the International Development Research Centre (IDRC). The funder had no involvement in the handling, peer review, or editorial decision for this article."The original version of this article has been updated.
- 4 September 2026
- Published by Frontiers Media SA in Frontiers in Health Services
- Vol. 6, 1974455
Open AccessCorrection: Scoping review of COVID-19 vaccines access, equity, hesitancy, and uptake in Kenya: lessons for the next pandemic
A Correction on: Okungu V, Mulupi S, Muriithi GN, Achala DM, Adote E, Mbachu CO, Beshaha SA, Nwosu CO and Ataguba JE-O (2026) The funding of the article processing charges was erroneously omitted. The following text has now been added to the Funding statement: "The article processing charges for this article were funded by the International Development Research Centre (IDRC). The funder had no involvement in the handling, peer review, or editorial decision for this article."The original version of this article has been updated.
- Open Access
- 13 May 2026
- Published by Frontiers Media SA in Frontiers in Health Services
- Vol. 6, 1648814
Scoping review of COVID-19 vaccines access, equity, hesitancy, and uptake in Kenya: lessons for the next pandemic
Introduction: The global rollout of COVID-19 vaccines was hampered by hesitancy, even as the pandemic intensified, underscoring the urgent need to strengthen vaccination efforts to reach most of the population. The primary objective of this review was to identify the critical barriers to equitable and timely access to and uptake of vaccines in Kenya with a view to mitigating the impacts of future pandemics, such as COVID-19. Methods: A digital search was conducted between February and March 17, 2024, and between December 2025 and February 2026, using four databases: PUBMED, Google Scholar, Cochrane Library, and Africa Journals Online. The search was limited to peer-reviewed articles only. The keywords used in the search were: COVID-19 vaccine + Access +Kenya; COVID-19 vaccine +Uptake+ Kenya; COVID-19 vaccine +Equity+ Kenya; COVID-19 vaccine +Hesitancy+ Kenya. The search was restricted to studies published from 2020, when the first vaccines were rolled out. Three researchers independently reviewed articles for inclusion and exclusion. Results: A total of 60 articles were included in the review. The main themes identified include geographic access, socio-demographic factors, economic and political determinants, and distrust in government systems. Among the critical determinants of COVID-19 vaccine uptake, confidence in the vaccine's efficacy and safety was a significant consideration. Geographic access to vaccination sites hindered uptake; for example, only 9.7% were vaccinated in a hard-to-reach county, compared to 53% in an urban county. Sociodemographic factors, including age, gender, level of education, occupation, and co-morbidity, significantly influenced vaccine uptake in Kenya. Above all, the Ministry of Health's failure to mount a convincing response to myths and misconceptions about the COVID-19 vaccine ultimately affected vaccination coverage nationwide. Conclusion: Future preparedness must ensure inclusive vaccine strategies led by governments with clear policies and tailored outreach. Communication should address vulnerable groups and reduce hesitancy. Improving access and engaging communities are key to equity. Social workers help build trust and local relevance.
- 13 May 2026
- Published by Frontiers Media SA in Frontiers in Health Services
- Vol. 6, 1648814
Open AccessScoping review of COVID-19 vaccines access, equity, hesitancy, and uptake in Kenya: lessons for the next pandemic
Introduction: The global rollout of COVID-19 vaccines was hampered by hesitancy, even as the pandemic intensified, underscoring the urgent need to strengthen vaccination efforts to reach most of the population. The primary objective of this review was to identify the critical barriers to equitable and timely access to and uptake of vaccines in Kenya with a view to mitigating the impacts of future pandemics, such as COVID-19. Methods: A digital search was conducted between February and March 17, 2024, and between December 2025 and February 2026, using four databases: PUBMED, Google Scholar, Cochrane Library, and Africa Journals Online. The search was limited to peer-reviewed articles only. The keywords used in the search were: COVID-19 vaccine + Access +Kenya; COVID-19 vaccine +Uptake+ Kenya; COVID-19 vaccine +Equity+ Kenya; COVID-19 vaccine +Hesitancy+ Kenya. The search was restricted to studies published from 2020, when the first vaccines were rolled out. Three researchers independently reviewed articles for inclusion and exclusion. Results: A total of 60 articles were included in the review. The main themes identified include geographic access, socio-demographic factors, economic and political determinants, and distrust in government systems. Among the critical determinants of COVID-19 vaccine uptake, confidence in the vaccine's efficacy and safety was a significant consideration. Geographic access to vaccination sites hindered uptake; for example, only 9.7% were vaccinated in a hard-to-reach county, compared to 53% in an urban county. Sociodemographic factors, including age, gender, level of education, occupation, and co-morbidity, significantly influenced vaccine uptake in Kenya. Above all, the Ministry of Health's failure to mount a convincing response to myths and misconceptions about the COVID-19 vaccine ultimately affected vaccination coverage nationwide. Conclusion: Future preparedness must ensure inclusive vaccine strategies led by governments with clear policies and tailored outreach. Communication should address vulnerable groups and reduce hesitancy. Improving access and engaging communities are key to equity. Social workers help build trust and local relevance.
- Open Access
- 1 December 2025
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 13
A qualitative examination of the distribution strategies, access, and equitable uptake of the COVID-19 vaccines in Kenya: lessons for the next pandemic
Background: The WHO and international partners identified vaccination against the coronavirus as one of the important public health interventions in controlling Corona Virus Disease (COVID-19) infections. The COVID-19 vaccine uptake was however low and characterized by inequitable distribution and access in Kenya. This study aimed to examine in depth the causes of inequity in vaccine uptake to inform the future rollout and successful uptake of new vaccines. Methods: The study employed a qualitative approach involving in-depth key informant interviews with stakeholders across various aspects of COVID-19 healthcare, public health, vaccine distribution, and community engagement in Kenya ( n = 32). Data were analyzed using the framework approach to allow for the identification, examination, and interpretation of patterns or themes emerging from the interview and review data. Findings: Centralized leadership provided by the Ministry of Health (MOH) utilized the existing distribution system, leveraging the Expanded Program on Immunization (EPI); enhancement of stakeholder collaboration and communication through government agencies, civil society, and community health workers was essential for the distribution of COVID-19 vaccines. Key barriers to vaccine uptake included organization and coordination of the vaccination rollout, socio-cultural barriers, and geographic challenges, particularly in rural areas, hindering vaccine access. Communication problems, particularly misinformation, were associated with public mistrust in vaccination efforts. Conclusion: Efforts to increase vaccine coverage should target organizational, social, political, and cultural norms to enhance access and uptake of quality vaccines. This study presents important lessons for health system adaptation, re-organization and preparations for future pandemics.
- 1 December 2025
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 13
Open AccessA qualitative examination of the distribution strategies, access, and equitable uptake of the COVID-19 vaccines in Kenya: lessons for the next pandemic
Background: The WHO and international partners identified vaccination against the coronavirus as one of the important public health interventions in controlling Corona Virus Disease (COVID-19) infections. The COVID-19 vaccine uptake was however low and characterized by inequitable distribution and access in Kenya. This study aimed to examine in depth the causes of inequity in vaccine uptake to inform the future rollout and successful uptake of new vaccines. Methods: The study employed a qualitative approach involving in-depth key informant interviews with stakeholders across various aspects of COVID-19 healthcare, public health, vaccine distribution, and community engagement in Kenya ( n = 32). Data were analyzed using the framework approach to allow for the identification, examination, and interpretation of patterns or themes emerging from the interview and review data. Findings: Centralized leadership provided by the Ministry of Health (MOH) utilized the existing distribution system, leveraging the Expanded Program on Immunization (EPI); enhancement of stakeholder collaboration and communication through government agencies, civil society, and community health workers was essential for the distribution of COVID-19 vaccines. Key barriers to vaccine uptake included organization and coordination of the vaccination rollout, socio-cultural barriers, and geographic challenges, particularly in rural areas, hindering vaccine access. Communication problems, particularly misinformation, were associated with public mistrust in vaccination efforts. Conclusion: Efforts to increase vaccine coverage should target organizational, social, political, and cultural norms to enhance access and uptake of quality vaccines. This study presents important lessons for health system adaptation, re-organization and preparations for future pandemics.
- Open Access
- 29 August 2025
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 19  (8) , e0012371
Strengthening the sustainability of neglected tropical disease programs in Rwanda: An assessment of access and utilization of domestically-financed services for soil-transmitted helminthiases and schistosomiasis
Introduction: Soil-transmitted helminth (STH) and schistosomiasis (SCH) infections remain some of the most prevalent neglected tropical diseases (NTDs), causing significant morbidity in most of sub-Saharan Africa (SSA), including Rwanda. With dwindling international funding for NTD services and recent commitments focused on other diseases considered easier to eliminate as a public health problem, it is essential to assess domestic financing sources’ scale, efficiency, and effectiveness. The study aims to strengthen domestic efforts towards sustainable financing for neglected tropical disease programs in Africa, particularly in Rwanda. Method: Up to 235 patients from 24 health centers in four districts of Rwanda were sampled for this survey. The districts selected had the highest number of STH and SCH based on routine data from June 2021 to December 2022, which is the window period of the study. We estimated affordability using the lowest-paid government worker (LPGW) and then compared this with household income and expenditure obtained from patients participating in the survey. Data was collected from August to September 2023. Limited secondary data were collected to complement primary data. Descriptive statistical analysis was used to present the findings. Results and Conclusions: The most available drugs were mebendazole, with 100% of facilities reporting no stockout. Praziquantel (PZQ) was the most unavailable drug, reporting 92% stockout at the time of the survey, mainly due to delays in getting supplies from MDA-implementing health facilities. Diagnostics for SCH are the most inaccessible lab services. On average, the total cost (both direct and opportunity cost) to access and utilize STH and SCH services was USD 0.72 (RWF 861.92) and USD 0.96 (RWF 1136.41) for male and female patients, respectively. Although the assessment revealed that treatment for STH and SCH was affordable for the LPGW, women pay a 33% higher cost than men to access NTD services. While services are generally satisfactory, the reimbursement processes are slow, hindering timely access and utilization of SCH and STH services at the health facilities in Rwanda. While the access and utilization of STH and SCH services in health centers are generally promising, the findings underscore the potential for improvement. By addressing the efficiency in the supply of praziquantel drugs and enhancing reimbursement timelines, we can ensure the continuity and effectiveness of these services, offering hope for a brighter future in the fight against neglected tropical diseases.
- 29 August 2025
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 19  (8) , e0012371
Open AccessStrengthening the sustainability of neglected tropical disease programs in Rwanda: An assessment of access and utilization of domestically-financed services for soil-transmitted helminthiases and schistosomiasis
Introduction: Soil-transmitted helminth (STH) and schistosomiasis (SCH) infections remain some of the most prevalent neglected tropical diseases (NTDs), causing significant morbidity in most of sub-Saharan Africa (SSA), including Rwanda. With dwindling international funding for NTD services and recent commitments focused on other diseases considered easier to eliminate as a public health problem, it is essential to assess domestic financing sources’ scale, efficiency, and effectiveness. The study aims to strengthen domestic efforts towards sustainable financing for neglected tropical disease programs in Africa, particularly in Rwanda. Method: Up to 235 patients from 24 health centers in four districts of Rwanda were sampled for this survey. The districts selected had the highest number of STH and SCH based on routine data from June 2021 to December 2022, which is the window period of the study. We estimated affordability using the lowest-paid government worker (LPGW) and then compared this with household income and expenditure obtained from patients participating in the survey. Data was collected from August to September 2023. Limited secondary data were collected to complement primary data. Descriptive statistical analysis was used to present the findings. Results and Conclusions: The most available drugs were mebendazole, with 100% of facilities reporting no stockout. Praziquantel (PZQ) was the most unavailable drug, reporting 92% stockout at the time of the survey, mainly due to delays in getting supplies from MDA-implementing health facilities. Diagnostics for SCH are the most inaccessible lab services. On average, the total cost (both direct and opportunity cost) to access and utilize STH and SCH services was USD 0.72 (RWF 861.92) and USD 0.96 (RWF 1136.41) for male and female patients, respectively. Although the assessment revealed that treatment for STH and SCH was affordable for the LPGW, women pay a 33% higher cost than men to access NTD services. While services are generally satisfactory, the reimbursement processes are slow, hindering timely access and utilization of SCH and STH services at the health facilities in Rwanda. While the access and utilization of STH and SCH services in health centers are generally promising, the findings underscore the potential for improvement. By addressing the efficiency in the supply of praziquantel drugs and enhancing reimbursement timelines, we can ensure the continuity and effectiveness of these services, offering hope for a brighter future in the fight against neglected tropical diseases.
- 13 December 2019
- Published by INESEG Yayincilik in International Journal of Health Services Research and Policy
- Vol. 4  (3) , 233-246
SUSTAINABILITY, EQUITY AND EFFECTIVENESS IN PUBLIC FINANCING FOR HEALTH IN UGANDA: AN ASSESSMENT OF MATERNAL AND CHILD HEALTH SERVICES
The aim of this assessment was to understand whether financing for maternal, child health and immunization services are sustainable, efficient, effective and equitable. Data sources included various national and international reports related to financing maternal and child health services. The results show that funding for maternal and child health (MCH) services are unsustainable over the long term because the main financing source are out-of-pocket (67% of total for MCH). However, Uganda shows higher efficiency in delivery as it has the lowest average cost per delivery (USD 50) compared to USD 70 (Kenya) and USD 95 (Ghana). Overall, MCH interventions being financed show some levels of effectiveness; e.g. maternal mortality rates dropped from 420/100000 live births in 2010 to 343/100000 live births in 2016; under-5 mortality rates reduced from 151/1000 live births in 2000 to 64/1000 live births in 2016. There are however, inequities by region, age, education status and wealth index; e.g. 37% in the poorest quintile have unmet family planning needs compared to only 23% in the wealthiest quintile. In conclusion, public financing for primary services such as MCH requires reforms to strengthen health sector performance. The reforms should address sustainable financing, efficiency, effectiveness and equity in service delivery.
- 13 December 2019
- Published by INESEG Yayincilik in International Journal of Health Services Research and Policy
- Vol. 4  (3) , 233-246
SUSTAINABILITY, EQUITY AND EFFECTIVENESS IN PUBLIC FINANCING FOR HEALTH IN UGANDA: AN ASSESSMENT OF MATERNAL AND CHILD HEALTH SERVICES
The aim of this assessment was to understand whether financing for maternal, child health and immunization services are sustainable, efficient, effective and equitable. Data sources included various national and international reports related to financing maternal and child health services. The results show that funding for maternal and child health (MCH) services are unsustainable over the long term because the main financing source are out-of-pocket (67% of total for MCH). However, Uganda shows higher efficiency in delivery as it has the lowest average cost per delivery (USD 50) compared to USD 70 (Kenya) and USD 95 (Ghana). Overall, MCH interventions being financed show some levels of effectiveness; e.g. maternal mortality rates dropped from 420/100000 live births in 2010 to 343/100000 live births in 2016; under-5 mortality rates reduced from 151/1000 live births in 2000 to 64/1000 live births in 2016. There are however, inequities by region, age, education status and wealth index; e.g. 37% in the poorest quintile have unmet family planning needs compared to only 23% in the wealthiest quintile. In conclusion, public financing for primary services such as MCH requires reforms to strengthen health sector performance. The reforms should address sustainable financing, efficiency, effectiveness and equity in service delivery.
- Open Access
- 13 December 2019
- Published by INESEG Yayincilik in International Journal of Health Services Research and Policy
- Vol. 4  (3) , 233-246
SUSTAINABILITY, EQUITY AND EFFECTIVENESS IN PUBLIC FINANCING FOR HEALTH IN UGANDA: AN ASSESSMENT OF MATERNAL AND CHILD HEALTH SERVICES
The aim of this assessment was to understand whether financing for maternal, child health and immunization services are sustainable, efficient, effective and equitable. Data sources included various national and international reports related to financing maternal and child health services. The results show that funding for maternal and child health (MCH) services are unsustainable over the long term because the main financing source are out-of-pocket (67% of total for MCH). However, Uganda shows higher efficiency in delivery as it has the lowest average cost per delivery (USD 50) compared to USD 70 (Kenya) and USD 95 (Ghana). Overall, MCH interventions being financed show some levels of effectiveness; e.g. maternal mortality rates dropped from 420/100000 live births in 2010 to 343/100000 live births in 2016; under-5 mortality rates reduced from 151/1000 live births in 2000 to 64/1000 live births in 2016. There are however, inequities by region, age, education status and wealth index; e.g. 37% in the poorest quintile have unmet family planning needs compared to only 23% in the wealthiest quintile. In conclusion, public financing for primary services such as MCH requires reforms to strengthen health sector performance. The reforms should address sustainable financing, efficiency, effectiveness and equity in service delivery.
- 13 December 2019
- Published by INESEG Yayincilik in International Journal of Health Services Research and Policy
- Vol. 4  (3) , 233-246
Open AccessSUSTAINABILITY, EQUITY AND EFFECTIVENESS IN PUBLIC FINANCING FOR HEALTH IN UGANDA: AN ASSESSMENT OF MATERNAL AND CHILD HEALTH SERVICES
The aim of this assessment was to understand whether financing for maternal, child health and immunization services are sustainable, efficient, effective and equitable. Data sources included various national and international reports related to financing maternal and child health services. The results show that funding for maternal and child health (MCH) services are unsustainable over the long term because the main financing source are out-of-pocket (67% of total for MCH). However, Uganda shows higher efficiency in delivery as it has the lowest average cost per delivery (USD 50) compared to USD 70 (Kenya) and USD 95 (Ghana). Overall, MCH interventions being financed show some levels of effectiveness; e.g. maternal mortality rates dropped from 420/100000 live births in 2010 to 343/100000 live births in 2016; under-5 mortality rates reduced from 151/1000 live births in 2000 to 64/1000 live births in 2016. There are however, inequities by region, age, education status and wealth index; e.g. 37% in the poorest quintile have unmet family planning needs compared to only 23% in the wealthiest quintile. In conclusion, public financing for primary services such as MCH requires reforms to strengthen health sector performance. The reforms should address sustainable financing, efficiency, effectiveness and equity in service delivery.
- Open Access
- 27 August 2019
- Published by INESEG Yayincilik in International Journal of Health Services Research and Policy
- Vol. 4  (2) , 131-144
EFFICIENCY, EQUITY, AND EFFECTIVENESS OF MALARIA FUNDING IN UGANDA: MAKING THE CASE FOR REFORMING PUBLIC FINANCING FOR HEALTH
Decreasing external funding for malaria requires high burden countries such as Uganda to increase domestic public financing to control and eliminate malaria. The aim of this study was to examine how the Government of Uganda, in collaboration with development partners and private sources of funding, has directed public resources in the recent past to help address the malaria burden. Data search and collection included national, regional and global reports and global data-bases. Government reports including National Development Plans, national health accounts (NHAs), national demographic health surveys, and other reports such as the Uganda Medicines Price Monitor, were included in the review. The findings indicate that government funding for malaria is limited (10% of total budget for malaria programming). Households (67%) are the main source of funds which makes malaria control in Uganda unsustainable. Public allocations are also inefficient with only 30% of funds allocated for preventive services contrary to global and national malaria control priorities. Evidence of inequity in the implementation of malaria programming are closely linked to poverty and ownership of preventive materials such as ITNs. Poor regions also report high malaria case incidence. Unavailability of anti-malarials is reported in lower level facilities serving mainly the poor. Overall progress in improving key malaria indicators is poor. There is also no correlation between expenditure on malaria and availability of ITNs (R 2 =0.6631). In conclusion, public financing for primary services such as malaria require reforms to strengthen health sector performance in terms of sustainability, efficiency, effectiveness and equity.
- 27 August 2019
- Published by INESEG Yayincilik in International Journal of Health Services Research and Policy
- Vol. 4  (2) , 131-144
Open AccessEFFICIENCY, EQUITY, AND EFFECTIVENESS OF MALARIA FUNDING IN UGANDA: MAKING THE CASE FOR REFORMING PUBLIC FINANCING FOR HEALTH
Decreasing external funding for malaria requires high burden countries such as Uganda to increase domestic public financing to control and eliminate malaria. The aim of this study was to examine how the Government of Uganda, in collaboration with development partners and private sources of funding, has directed public resources in the recent past to help address the malaria burden. Data search and collection included national, regional and global reports and global data-bases. Government reports including National Development Plans, national health accounts (NHAs), national demographic health surveys, and other reports such as the Uganda Medicines Price Monitor, were included in the review. The findings indicate that government funding for malaria is limited (10% of total budget for malaria programming). Households (67%) are the main source of funds which makes malaria control in Uganda unsustainable. Public allocations are also inefficient with only 30% of funds allocated for preventive services contrary to global and national malaria control priorities. Evidence of inequity in the implementation of malaria programming are closely linked to poverty and ownership of preventive materials such as ITNs. Poor regions also report high malaria case incidence. Unavailability of anti-malarials is reported in lower level facilities serving mainly the poor. Overall progress in improving key malaria indicators is poor. There is also no correlation between expenditure on malaria and availability of ITNs (R 2 =0.6631). In conclusion, public financing for primary services such as malaria require reforms to strengthen health sector performance in terms of sustainability, efficiency, effectiveness and equity.
- Open Access
Medicine Prices, Availability, and Affordability in Private Health Facilities in Low-Income Settlements in Nairobi County, Kenya
Medicine prices are a major determinant of access to healthcare. Owing to low availability of medicines in the public health facilities and poor accessibility to these facilities, most low-income residents pay out-of-pocket for health services and transport to the private health facilities. In low-income settlements, high retail prices are likely to push the population further into poverty and ill health. This study assessed the retail pricing, availability, and affordability of medicines in private health facilities in low-income settlements within Nairobi County. Medicine prices and availability data were collected between September and December 2016 at 45 private healthcare facilities in 14 of Nairobi’s low-income settlements using electronic questionnaires. The International Medical Products Price Guide provided international medicine reference prices for comparison. Affordability and availability proxies were calculated according to existing methods. Innovator brands were 13.8 times more expensive than generic brands. The lowest priced generics and innovator brands were, on average, sold at 2.9 and 32.6 times the median international reference prices of corresponding medicines. Assuming a 100% disposable income, it would take 0.03 to 1.33 days’ wages for the lowest paid government employee to pay for treatment courses of selected single generic medicines. Medicine availability in the facilities ranged between 2% and 76% (mean 43%) for indicator medicines. Prices of selected medicines varied within the 14 study regions. Retail medicine prices in the low-income settlements studied were generally higher than corresponding international reference prices. Price variations were observed across different regions although the regions comprise similar socioeconomic populations. These factors are likely to impact negatively on healthcare access.
Open AccessMedicine Prices, Availability, and Affordability in Private Health Facilities in Low-Income Settlements in Nairobi County, Kenya
Medicine prices are a major determinant of access to healthcare. Owing to low availability of medicines in the public health facilities and poor accessibility to these facilities, most low-income residents pay out-of-pocket for health services and transport to the private health facilities. In low-income settlements, high retail prices are likely to push the population further into poverty and ill health. This study assessed the retail pricing, availability, and affordability of medicines in private health facilities in low-income settlements within Nairobi County. Medicine prices and availability data were collected between September and December 2016 at 45 private healthcare facilities in 14 of Nairobi’s low-income settlements using electronic questionnaires. The International Medical Products Price Guide provided international medicine reference prices for comparison. Affordability and availability proxies were calculated according to existing methods. Innovator brands were 13.8 times more expensive than generic brands. The lowest priced generics and innovator brands were, on average, sold at 2.9 and 32.6 times the median international reference prices of corresponding medicines. Assuming a 100% disposable income, it would take 0.03 to 1.33 days’ wages for the lowest paid government employee to pay for treatment courses of selected single generic medicines. Medicine availability in the facilities ranged between 2% and 76% (mean 43%) for indicator medicines. Prices of selected medicines varied within the 14 study regions. Retail medicine prices in the low-income settlements studied were generally higher than corresponding international reference prices. Price variations were observed across different regions although the regions comprise similar socioeconomic populations. These factors are likely to impact negatively on healthcare access.
- Open Access
- 1 April 2019
- Published by INESEG Yayincilik in International Journal of Health Services Research and Policy
- Vol. 4  (1) , 31-42
ASSESSING INSTITUTIONAL CAPACITY OF COUNTY HEALTH DEPARTMENTS IN KENYA USING THE HEALTH SYSTEMS FRAMEWORK: IMPLICATIONS FOR SERVICE DELIVERY AND OUTCOMES
The study used the county institutional capacity assessment tool (CICAT) to assess the capacities of selected county health departments (CHDs) along the World Health Organization (WHO) health systems framework that is organized around the six building blocks. The aim was to determine the current status of the six health system building blocks in Kenya’s county health departments. The article emanates from data collected for a technical report on county institutional capacity assessment. Data were analysed using Microsoft Excel spreadsheet and thematic analysis. The overall performance of the counties was 54% indicating average capacity. The performance scores were: leadership and governance (39%), human resources for health (44%), health information systems (66%), medical products and technologies (50%), health system financing (50%), and service delivery (71%). There was no statistically significant difference in the overall performance of the counties (p= 0.892). The key issues in some of the worst performing building blocks included poor work-planning and lack of transparency in budgeting and expenditure, low funding and irregular disbursements of health budgets, lack of key policies, e.g. workforce strategy and commodity supply chain. In conclusion, the study proved that the CICAT is useful for assessing the process of strengthening health systems in Kenyan counties.
- 1 April 2019
- Published by INESEG Yayincilik in International Journal of Health Services Research and Policy
- Vol. 4  (1) , 31-42
Open AccessASSESSING INSTITUTIONAL CAPACITY OF COUNTY HEALTH DEPARTMENTS IN KENYA USING THE HEALTH SYSTEMS FRAMEWORK: IMPLICATIONS FOR SERVICE DELIVERY AND OUTCOMES
The study used the county institutional capacity assessment tool (CICAT) to assess the capacities of selected county health departments (CHDs) along the World Health Organization (WHO) health systems framework that is organized around the six building blocks. The aim was to determine the current status of the six health system building blocks in Kenya’s county health departments. The article emanates from data collected for a technical report on county institutional capacity assessment. Data were analysed using Microsoft Excel spreadsheet and thematic analysis. The overall performance of the counties was 54% indicating average capacity. The performance scores were: leadership and governance (39%), human resources for health (44%), health information systems (66%), medical products and technologies (50%), health system financing (50%), and service delivery (71%). There was no statistically significant difference in the overall performance of the counties (p= 0.892). The key issues in some of the worst performing building blocks included poor work-planning and lack of transparency in budgeting and expenditure, low funding and irregular disbursements of health budgets, lack of key policies, e.g. workforce strategy and commodity supply chain. In conclusion, the study proved that the CICAT is useful for assessing the process of strengthening health systems in Kenyan counties.
- 29 March 2019
- Published by Taylor & Francis in Health Systems & Reform
- Vol. 5  (2) , 145-157
Does the Informal Sector in Kenya Have Financial Potential to Sustainably Prepay for Health Care? Implications for Financing Universal Health Coverage in Low-Income Settings
Kenya currently lacks evidence on whether income in the informal sector is sustainable and predictable, and therefore able to support financing of UHC. This paper demonstrates the financial potential of informal sector entities to sustainably finance UHC in Kenya. Data were collected using a standardized questionnaire on the following topics: nature and sustainability of informal sector entities, indicators of financial potential, and socioeconomic status. Both descriptive and multivariate analyses were used. The findings indicate that income in the informal sector is generally low although investors in health/medical, stationery, entertainment, manufacturing & craft as well as transportation, tend to have higher and consistent incomes than most others in both sites. Mean monthly incomes ranged from 16.7 USD (lowest) to 786.5 USD (highest). The urban informal sector recorded higher mean monthly incomes of 195.8 USD compared to 77.9 USD in the rural area (p<0.001). The most sustainable entities in the urban area included stationery (67%), repair and maintenance (50%), food vending (49%), shop-keeping (48%) and cloth & beauty products (43%). Farming (90%), manufacturing & craft (86%) and health/medical (100%) were the most sustainable in the rural area. Key predictors of sustainable informal sector entities include monthly expenditure patterns, gender, marital status, household structure, number of employees in an entity, land ownership +in the rural area, and number of entities owned. Informal sector entities are mostly unsustainable meaning that the majority of premium contributors will not be consistent in payment and will likely to require subsidies.
- 29 March 2019
- Published by Taylor & Francis in Health Systems & Reform
- Vol. 5  (2) , 145-157
Does the Informal Sector in Kenya Have Financial Potential to Sustainably Prepay for Health Care? Implications for Financing Universal Health Coverage in Low-Income Settings
Kenya currently lacks evidence on whether income in the informal sector is sustainable and predictable, and therefore able to support financing of UHC. This paper demonstrates the financial potential of informal sector entities to sustainably finance UHC in Kenya. Data were collected using a standardized questionnaire on the following topics: nature and sustainability of informal sector entities, indicators of financial potential, and socioeconomic status. Both descriptive and multivariate analyses were used. The findings indicate that income in the informal sector is generally low although investors in health/medical, stationery, entertainment, manufacturing & craft as well as transportation, tend to have higher and consistent incomes than most others in both sites. Mean monthly incomes ranged from 16.7 USD (lowest) to 786.5 USD (highest). The urban informal sector recorded higher mean monthly incomes of 195.8 USD compared to 77.9 USD in the rural area (p<0.001). The most sustainable entities in the urban area included stationery (67%), repair and maintenance (50%), food vending (49%), shop-keeping (48%) and cloth & beauty products (43%). Farming (90%), manufacturing & craft (86%) and health/medical (100%) were the most sustainable in the rural area. Key predictors of sustainable informal sector entities include monthly expenditure patterns, gender, marital status, household structure, number of employees in an entity, land ownership +in the rural area, and number of entities owned. Informal sector entities are mostly unsustainable meaning that the majority of premium contributors will not be consistent in payment and will likely to require subsidies.